Showing results (251-260 of 333) with videos related to

Sort By:
Pageof 34
Scientific Reports|April 30, 2021
Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host diseaseSatoru Hagiwara, Tomohiro Watanabe, Masatoshi Kudo, et al.
JTO Clinical and Research Reports|November 24, 2025
RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated EGFR-Mutated Metastatic NSCLCMakoto Nishio, Takashi Seto, Martin Reck, et al.
International Journal of Clinical Oncology|August 7, 2023
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1Makoto Nishio, Yuichiro Ohe, Satoshi Ikeda, et al.
JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.
Japanese Journal of Clinical Oncology|June 27, 2019
Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L)Tatsuo Kimura, Tomoya Kawaguchi, Yasutaka Chiba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2022
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L StudyHirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori, et al.
Scientific Reports|August 7, 2019
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencingKazuko Sakai, Masayuki Takeda, Shigeki Shimizu, et al.
Lung Cancer (Amsterdam, Netherlands)|April 27, 2022
Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L)Hidetoshi Hayashi, Kimio Yonesaka, Atsushi Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2025
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 TrialCharles M Rudin, Melissa L Johnson, Luis Paz-Ares, et al.
Thoracic Cancer|February 13, 2025
Detection of Overlooked Rare EGFR Mutations in Non-small Cell Lung Cancer Using Multigene TestingNaoki Shiraishi, Takayuki Takahama, Kazuko Sakai, et al.
Pageof 34